In December, CVS Health entered into a definitive agreement to acquire all outstanding shares of Aetna for approximately $69 billion in cash and stock.
At a special meeting March 13, 98 percent of CVS shareholders’ ballots were in favor of the transaction. Among Aetna shareholders, about 97 percent of votes cast were in favor of the deal.
The parties expect the transaction, which still needs approval from the Department of Justice, to close in the second half of 2018.
More articles on payer issues:
UnitedHealth taps former GlaxoSmithKline CEO to lead Optum: 4 things to know
Some Anthem patients afraid to use ED under new policy: 6 things to know
How health insurers game Medicare Advantage ratings to boost bonus payments
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
